Non target lesions are monitored through periodic imaging studies alongside regular assessments of target lesions. While target lesions are measured and compared using criteria such as RECIST (Response Evaluation Criteria in Solid Tumors), non target lesions are typically assessed for changes in size, number, and overall appearance. The presence of new non target lesions can also be a significant indicator of disease progression.
